A study presented at the American Diabetes Association’s 75th Scientific Sessions shows that gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, may alter the brain’s response to food, possibly reducing cravings and increasing satisfaction while eating.
IFT Daily News
Leave a Comment